Investigation on the effects of memantine on psychiatric symptoms and sleep disturbances in patients with Alzheimer's disease

Investigation on the effects of memantine on psychiatric symptoms and sleep disturbances in patients with Alzheimer's disease - Effects of memantine on BPSD and sleep disturbances

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006388

Enrollment

Registered

2011-09-21

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients 1) who meet NINCDS-ADRDA criteria for Alzheimer's disease, 2) whose Neuropsychiatric Inventory core is over 4, and 3) who understand the points of this study and give informed-consent in literature.

Exclusion criteria

Exclusion criteria: Patients 1) who have other types of dementia (e.g. vascular dementia, dementia with Lewy bodies), 2) who have schizophrenia, and 3) who have severe medical illness that may prevent this study.

Design outcomes

Primary

Measure	Time frame
Neuropsychiatric Inventory, MMSE, polysomnography, actigram	—

Countries

Japan

Contacts

Public ContactHideto Shinno

Kagawa University School of Medicine Department of Neuropsychiatry

shinnoh@med.kagawa-u.ac.jp087-891-2167

Outcome results